Smithbridge Asset Management Inc Bristol Myers Squibb CO Transaction History

Smithbridge Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $149,935 - $167,650	-2,590 Reduced 7.4%	32,396 $1.88 Million
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $22,871 - $25,395	-359 Reduced 1.02%	34,986 $2.24 Million
Q2 2023 Jul 18, 2023	SELL	$63.71 - $70.74 $2,675 - $2,971	-42 Reduced 0.12%	35,345 $2.54 Million
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $2,759 - $3,130	42 Added 0.12%	35,387 $2.45 Million
Q4 2022 Mar 01, 2023	BUY	$68.48 - $81.09 $2.42 Million - $2.87 Million	35,345 New	35,345 $2.54 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Smithbridge Asset Management Inc with notifications on news.